Dr Marcus H. Snow: Biosimilar Treatments in Children

Marcus H. Snow, MD

Marcus H. Snow, MD, Assistant Professor of Rheumatology, University of Nebraska, discusses the use of biosimilar treatments in children.

Transcript:

Are there special considerations when using biosimilars in children?

Generally, no. Ultimately, in the pediatric realm, we end up having a lot of extrapolation of data and the biosimilars with the pediatric population should not be; ideally, this would be studied as much as it is in the adult world, but we just do not have that as often.